Last Round
Accelerator
Feb 5, 2026
Total Funding Raised
$17.05M
Company Overview
ALTx Therapeutics is a drug discovery company that develops precision cancer therapies targeting the Alternative Lengthening of Telomeres (ALT) pathway.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
precision medicineoncologydrug discoverybiotechnologysmall molecule inhibitorsALT pathwayalternative lengthening of telomeresdiagnostic biomarkerspatient stratificationbiotech startupcancer therapeuticscompanion diagnosticstherapeutic pipelinedrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALTx Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
ALTx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 5, 2026 |
ALTx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Accelerator |
| The Francis Crick Institute | Accelerator |
| Cancer Research Horizons | Accelerator |
ALTx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ALTx Therapeutics's valuation, stock price, and market status.